PhD Defences - 2002

Here you may find the PhD defences which has taken place recently at the Danish University of Pharmaceutical Sciences.

PhD Student (Department)	Title of Lecture	Time	Date
Jesper Davidsen (F)	Phospholipase A2 Triggered Targeting of Liposomes: Tumor Specific Delivery of Concentional Chemotherapeutic Agents and Novel Liposomal Prodrugs of Anticancer Etherlipids	15.00	Tuesday 17 December 2002 in Auditorium 3
Hanne Ziegler (M)	Antiplasmodial Activity of Natural Products: Effect of Incorporation into Erythrocyte Membrane	14.00	Friday 22 November 2002
Majid Sairafianpour (M)	Iranian Medicinal Plants and Antiparasitic Compounds; from Ethnobotany to Contemporary Scientific Evidence	14.00	Friday 8 November 2002
Anne Mette Beier (F)	Chitosan Microparticles as a Drug Delivery System for Protein Vaccines	14.00	Monday 28 October 2002
Jørgen Eskildsen (M)	Functionalization of Pyrazole 1-Oxides via Metalated Intermediates and Toward the Synthesis of the Biaryl Portion of Vancomycin	14.00	Friday 25 October 2002
Christian Wenzel Tornøe (M)	Solid Phase Regiospecific Cycloadditions Providing Novel Peptidotriazoles as Protease Inhibitors	15.00	Thursday 24 October 2002 in Auditorium 3
Henrik Kjeldtoft Frederiksen (F)	Investigation on Lipid and Polystyrene Matrix Formulations Designed to Reduce the Aquatic Toxicity of the Pyrethroid GCH	14.00	Wednesday 23 October 2002
Liza Nielsen Garriques (F)	Studies on Insulin Fibril Formation	14.00	Tuesday 24 September 2002
Anders Fuglsang (B)	Cadiovascular Effects of Fermented Milk and Milk-Derived Peptides: Inhibition of Circulatory Angiotensin Converting Enzyme?	15.00	Friday 20 September 2002 in Auditorium 4
Anita Johansen (F)	Agglomeration in a High Shear Mixer - an Investigation of Binder Liquid Requirement and Agglomerate Formation nad Growth Mechanisms	14.00	Friday 6 September 2002
Jørgen Olsen (A)	Reactive Drug Metabolites. Formation, Metabolism and Reactivity of Acyl Coenzyme A Thioesters in vitro and in vivo	14.00	Monday 2 September 2002 in Auditorium 3
Helle Hagen Sveigaard (B)	Biological Barriers to Drugs for the Central Nervous System	14.00	Friday 16 August 2002
Henrik Toft Simonsen (M)	Ethnopharmacological and Phytochemical Investigation of Melicope Species from Réunion Island	14.00	Friday 28 June 2002
Caspar Christensen (M)	Development of Zinc Binding Peptidomimetics for Inhibition of Matrix Metalloproteineases by Application of a Combinatorial Solid Phase Approach	14.00	Friday 28 June 2002 in Auditorium 3
Søren Thor Larsen (B)	Adjuvant Effect of Phthalates and Monophthalates in a Murine Injection Model	14.00	Wednesday 26 June 2002
Dorte Krehan Seir Petersen (M)	Ionotropic GABA Receptor Ligands: Synthesis and Characterization	14.00	Tuesday 11 June 2002
Nina Hagen (A)	Characterisation of Recombinant Cytochrome P450s: An In Vitro Model for Preclinical Drug Metabolism	14.00	Monday 10 June 2002
Martin Mortensen (B)	GABAa Receptor Pharmacology: Electrophysiological Studies of Agonist Activity on Reconstituted Human GABAa Receptors	12.00	Monday 3 June 2002
Jacob Stenmann Valsborg	Design and Synthesis of Radioligands in Drug Development	14.00	Wednesday 29 May 2002 in Auditorium 3
Shiba Bahadur Karkee (S)	Issues in Antibacterial Provision in Primary Health Care in Nepal	14.00	Wednesday, 8 May 2002 in Auditorium 3
Mette Guldbrandt (M)	Synthesis, Stereochemistry, Pharmacology and Blood-Brain Barrier Penetration of (S)-Glutamic Acid Receptor Ligands	14.00	Wednesday, 8 May 2002
Claus Christophersen (M)	New and Efficient Synthetic Methods Based on Organometallic Compounds for Preparation of Medicinally Relevant Thiophenes	14.00	Monday, 6 May 2002
Jon Bondebjerg (M)	A Solid Phase Approach to Thioether Cyclized Peptidomimetic Scaffolds and Conotoxin Analogs	14.00	Thursday, 2 May 2002 in Auditorium 3
Anders Hogner (M)	Structural Basis for AMPA Receptor Activation, Deactivation and Ligand Selectivity	14.00	Thursday, 2 May 2002
Lennart Bunch (M)	Design and Synthesis of New Glutamic Acid Receptor Ligands	13.00	Monday, 22 April 2002
Thomas Balle (M)	Development of Selective alpha1-Adrenoceptor Antagonists with the Purpose of Studying alpha1-Adrenoceptors in the Central Nervous System with PET.	15.00	Friday 22 March 2002 in Auditorium 4
Nina Rønsted (M)	Towards a Natural Classification of Plantago - Chemical and Molecular Systematics	15.00	Friday 22 March 2002 in Auditorium 3
Patrizia Calí (M)	Synthesis of Aromatic and Heteroaromatic Amino Acids	14.00	Monday 18 March 2002
Tina Bjeldskov Pedersen (F)	Liposomes in Relation to Peptide Interactions and Potential Drug Delivery Aspects	14.00	Monday, 4 March 2002 in U7/U8
Lars-Erik Broksø Kyhl (B)	Population Pharmacokinetics of Cyclosporine: Influence of Covariables and Assessment of Cyclosporine Absorption in Kidney, Lung, Heart, Heart+Lung and Liver Transplanted Patients	14.00	Thursday, 28 February 2002
Martin Wenckens (M)	Synthesis and Biological Evaluation of Novel N-Alkoxypyrazoles as Biomimetics for the Phenoxy Group in Tamoxifen	14.00	Monday 25 February 2002
Birna Trap (S)	The Practices of Dispensing and Non-Dispensing Doctors in Zimbabwe	14.00	Monday 18 February 2002
Marie-Louise Lunn (M)	From Gene to Crystal Structure - a Study of the Ligand Binding Domain of AMPA and Kainate Receptors.	10.00	Friday 1 February 2002 in auditorium 3
Gitte Petersen (B)	Characterization and Partial Purification of N-Acylethanolamine Phospholipid-Hydrolyzing Phospholipase D	14.00	Friday 1 February 2002 in auditorium 3
René Holm (F)	Intestinal Lymphatic Transport and Portal Absorption of Lipophilic Drugs after Oral Administration in a Lipid Vehicle	14.00	Friday 11 January 2002 in auditorium 3
Jesper Langgaard Kristensen (M)	Metalation, Halogen-Metal Exchange and Pd(0)-Catalyzed Cross-Coupling Reactions. Application to the Synthesis of Substituted Aromatic and Heteroaromatic Systems	14.00	Monday 7 January 2002 in auditorium 3